Article
IDH1 R132C and ERC2 L309I Mutations Contribute to the Development of Maffucci's Syndrome.
Frontiers in endocrinology - 1 Jan 2021
Cheng Peng, Chen Kun, Zhang Shu, Mu Ke-Tao, Liang Shuang, Zhang Ying
Abstract excerpt
Background: Maffucci's syndrome is characterized by the coexistence of multiple enchondromas and soft-tissue hemangiomas. It has been clear that somatic mosaic isocitrate dehydrogenase type 1 (IDH1) or isocitrate dehydrogenase type 2 (IDH2) mutations are associated with Maffucci's syndrome and Ollier disease, but the mechanisms underlying hemangiomas of the Maffucci's syndrome is still obscure. This study aimed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
